List of SBIR/STTR awards granted to FreeFlow Medical Devices LLC
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to FreeFlow Medical Devices LLC in March, 2021 for $223,937.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL156321-01A1 | Phase I | 223,937 | March 19, 2021 | |||||||
A STTR Phase I contract was awarded to FreeFlow Medical Devices LLC in September, 2018 for $245,001.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41NS103704-01A1 | Phase I | 245,001 | September 1, 2018 | |||||||
A STTR Phase II contract was awarded to FreeFlow Medical Devices LLC in September, 2020 for $1,384,382.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 2R42NS103704-02A1 | Phase II | 1,384,382 | September 30, 2020 | |||||||
A SBIR Phase I contract was awarded to FreeFlow Medical Devices LLC in September, 2019 for $224,554.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK123907-01 | Phase I | 224,554 | September 15, 2019 | |||||||
A SBIR Phase I contract was awarded to FreeFlow Medical Devices LLC in April, 2022 for $299,429.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK132989-01 | Phase I | 299,429 | April 1, 2022 | |||||||
A SBIR Phase I contract was awarded to FreeFlow Medical Devices LLC in January, 2018 for $222,842.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI136573-01 | Phase I | 222,842 | January 15, 2018 | |||||||
A SBIR Phase II contract was awarded to FreeFlow Medical Devices LLC in August, 2023 for $801,880.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DK135256-01A1 | Phase II | 801,880 | August 1, 2023 |
